Catalyst Pharmaceuticals(CPRX) - 2023 Q4 - Annual Report

Index to Financial Statements [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 Commission File No. 001-33057 355 Alhambra Circle, Suite 801 Coral Gables, Florida 33134 (Address of principal executive offices) (Zip Code) Title of Each Class Ticker Symbol Name of Exchange on Which Registered Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market Indicate by check mark whether the registrant has submitted ...